Brunei to resume AstraZeneca Covid-19 vaccine use with conditions

FILE PHOTO: A test tube labeled with the vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. - Reuters

BANDAR SERI BEGAWAN, April 20 (Xinhua): The Brunei government has announcd that the administration of AstraZeneca Covid-19 vaccine can resume in the country with some criteria, after two weeks of reviewing on adverse side effects.

According to Brunei's Ministry of Health, since the temporary pause on the use of the AstraZeneca Covid-19 vaccine on April 6, it had reviewed reports from other countries of very rare cases of blood clots with low platelets following vaccination with the AstraZeneca Covid-19 vaccine.